<!-- mobian-agent-page publisher="time" canonical="https://time.com/6233604/moderna-omicron-booster-data/" -->

---
title: Moderna Says Its Omicron Booster Works Against New Variants
description: The company says the Omicron booster, which targets BA.4 and BA.5, protects against those variants and against BQ.1. Here&#x27;s what to know.
canonical: https://time.com/6233604/moderna-omicron-booster-data/
author: Alice Park
article:opinion: false
article:content_tier: free
article:published_time: 2022-11-14T16:12:53.000Z
article:modified_time: 2026-02-24T15:02:52.235Z
article:section: Health
og:title: Moderna&#x27;s Omicron Booster Works Against New Variants, Company Says
og:description: The booster helps protect against the BA.4 and BA.5 Omicron variants
og:url: https://time.com/6233604/moderna-omicron-booster-data/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&amp;width=2400&amp;quality=75&amp;auto=webp&amp;crop=16:9
og:image:width: 1200
og:image:height: 675
og:image:alt: moderna-omicron-booster
og:type: article
twitter:card: summary_large_image
twitter:title: Moderna&#x27;s Omicron Booster Works Against New Variants, Company Says
twitter:description: The booster helps protect against the BA.4 and BA.5 Omicron variants
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&amp;width=2400&amp;quality=75&amp;auto=webp&amp;crop=16:9
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&width=2400&quality=75&auto=webp&crop=16:9)


# Moderna's Omicron Booster Works Against New Variants, Company Says


![Alice Park](https://static.time.com/v3/assets/bltea6093859af6183b/blt9b1ff6b12c3a4c3f/698a0b4397cdff3e366ba723/200116_Time_Headshots_Day552832-e1583529256299.jpg?branch=production&width=3840&quality=75&auto=webp&crop=1:1)

by 

[Alice Park](https://time.com/author/alice-park/)


![Alice Park](https://static.time.com/v3/assets/bltea6093859af6183b/blt9b1ff6b12c3a4c3f/698a0b4397cdff3e366ba723/200116_Time_Headshots_Day552832-e1583529256299.jpg?branch=production&width=96&quality=75&auto=webp)

## Alice Park


Senior Correspondent

Nov 14, 2022 4:12 PM UTC

![moderna-omicron-booster](https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&width=3840&quality=75&auto=webp&crop=3:2)

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the Moderna logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the Moderna logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)Artur Widak/NurPhoto—Getty Images

![Alice Park](https://static.time.com/v3/assets/bltea6093859af6183b/blt9b1ff6b12c3a4c3f/698a0b4397cdff3e366ba723/200116_Time_Headshots_Day552832-e1583529256299.jpg?branch=production&width=3840&quality=75&auto=webp&crop=1:1)

by 

[Alice Park](https://time.com/author/alice-park/)


![Alice Park](https://static.time.com/v3/assets/bltea6093859af6183b/blt9b1ff6b12c3a4c3f/698a0b4397cdff3e366ba723/200116_Time_Headshots_Day552832-e1583529256299.jpg?branch=production&width=96&quality=75&auto=webp)

## Alice Park


Senior Correspondent

Nov 14, 2022 4:12 PM UTC

In a news [release](https://investors.modernatx.com/news/news-details/2022/Modernas-BA.4BA.5-Targeting-Bivalent-Booster-mRNA-1273.222-Meets-Primary-Endpoint-of-Superiority-Against-Omicron-Variants-Compared-to-Booster-Dose-of-mRNA-1273-in-Phase-23-Clinical-Trial/default.aspx) published Nov. 14, Moderna said its updated Omicron booster shot targeting the variants BA.4 and BA.5 produced higher levels of antibodies against those versions of the virus than its original shot did.

Compared to Moderna’s original booster, the Omicron booster generated a 15.1-fold increase in levels of antibodies against the BA.4 and BA.5 variants in a study involving 511 people who had already been vaccinated and boosted. Among these participants, people who had not experienced a prior COVID-19 infection showed the strongest response, with levels of BA.4 and BA.5 antibodies around 26-fold higher than levels prior to the booster. Those who had had previous infections showed a nearly 10-fold increase in these antibodies.

The results are part of an ongoing study evaluating the booster shot, which the U.S. Food and Drug Administration (FDA) [authorized](https://time.com/6210478/cdc-fall-booster-shots-omicron/) in Aug. 2022 to [enhance people’s protection against the BA.4 and BA.5 variants](https://time.com/6214187/new-omicron-booster-antibodies/). At the time, these variants combined accounted for nearly all of the new infections in the country, but the quickly evolving virus has already mutated to produce newer variants that have [supplanted](https://covid.cdc.gov/covid-data-tracker/#variant-proportions) them in dominance. As of the first week in November, [BQ.1 and BQ.1.1](https://time.com/6222686/covid-19-new-subvariants-bq1-bq11/) combined caused 44.2% of new infections in the U.S., while BA.5 and BA.4 accounted for 29.8% of cases.

Moderna’s scientists also reported preliminary data on how well its BA.4 and BA.5-targeting booster could neutralize BQ.1\. In studies involving 40 people, the company said the bivalent booster also produced strong neutralizing antibodies against BQ.1, although these levels were five-fold lower than those generated against BA.4 and BA.5.

**Read More**: [_BQ.1, BQ.1.1, BF.7, and XBB: Why New COVID-19 Variants Have Such Confusing Names_](https://time.com/6229947/how-are-covid-19-variants-named/)

While the data are encouraging, researchers warn that new variants may dominate the coming winter season, and that determining how well existing vaccines and boosters can neutralize these new versions of the virus will be critical to avoiding surges and increased hospitalizations and deaths from COVID-19\. Already, some scientists have [documented](https://time.com/6230059/covid-19-variants-omicron-vaccine/) that current vaccines and past infections don’t generate robust levels of neutralizing antibody responses against BQ.1, BQ.1.1, and another variant that’s circulating in Singapore called XBB. As BQ.1 and BQ.1.1 become dominant in the U.S., health officials will be evaluating how well the bivalent BA.4 and BA.5 booster made by both Moderna and [Pfizer-BioNTech](https://time.com/6221741/pfizer-bivalent-booster-antibodies-omicron/) can stand up to them.

Moderna’s scientists also reported that an earlier booster dose it developed, which targeted an earlier variant, BA.1, also generated higher levels of antibodies that could neutralize BA.1, BA.4, and BA.5\. This booster has not been authorized by the U.S. FDA, which [requested](https://time.com/6210478/cdc-fall-booster-shots-omicron/) the company to develop the bivalent BA.4 and BA.5 booster instead. The BA.1 bivalent booster, however, was [authorized in Canada](https://www.canada.ca/en/health-canada/news/2022/09/health-canada-authorizes-first-bivalent-covid-19-booster-for-adults-18-years-and-older.html) and the [U.K](https://www.gov.uk/government/news/first-bivalent-covid-19-booster-vaccine-approved-by-uk-medicines-regulator).

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6233604/moderna-omicron-booster-data/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6233604/moderna-omicron-booster-data/"},"headline":"Moderna's Omicron Booster Works Against New Variants, Company Says","datePublished":"2022-11-14T16:12:53.000Z","dateModified":"2026-02-24T15:02:52.235Z","description":"The booster helps protect against the BA.4 and BA.5 Omicron variants.","url":"https://time.com/6233604/moderna-omicron-booster-data/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt6bae681713e1653c/698a37e7db29873c68268728/moderna-omicron-booster.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"moderna-omicron-booster","caption":"moderna-omicron-booster","creditText":"Artur Widak/NurPhoto—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6233604/moderna-omicron-booster-data/","name":"Moderna's Omicron Booster Works Against New Variants, Company Says"}}]}]
```

